Related Experiment Video
Updated: Jan 17, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
[Research on Application of Medical Device Real-World Evidence in Regulatory Decisions of the United States]
Xiaofang Gu1, Yuanyuan Hou1, Kai Lin1
1Hainan Service Center for Drug and Medical Device Evaluation, Haikou, 570216.
Abstract:
In recent years, with the development of big data application technology, the real-world data and the corresponding generated real-world evidence have attracted the attention of healthcare regulatory authorities around the world. Regulators recognize that real-world research with specific purposes using real-world data can provide important evidence for regulatory decisions. A total of 90 instances of publicly released on the application of real-world evidence to support regulatory decisions of U. S. Food and Drug Administration are explored, and the positioning and value of real-world evidence in U. S. Food and Drug Administration regulatory decisions are summarized and analyzed, providing references for the use of real-world data and real-world evidence to promote medical devices whole cycle regulation in China.
Related Concept Videos
Drug Regulation
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioequivalence studies: Biowaivers
Drug Control Governance: Regulatory Bodies and Their Impact
Clinical Trials
There are four phases in a clinical trial. A phase one...

